In the News
Anti-competitive behaviour in market for hydrocortisone tablets

4th March 2017
On the surface this is a classic example of anti-competitive behaviour in a duopolistic market.
The CMA has alleged that Concordia and Actavis signed illegal agreements which enabled high prices for a life-saving drug to be prolonged. Naturally the announcement has brought a wave of criticism for the businesses involved because the cost of higher prices for drugs routinely used in the NHS are ultimately paid for by the taxpayer.
You can read more about the case here on the CMA website
Two pharmaceutical firms accused of driving up prices of an NHS life-saving drug with secret deal https://t.co/ovzRkL6P6j
— The Independent (@Independent) March 3, 2017
You might also like
Competition and Markets Authority (CMA)
Study Notes

Ladbrokes and Coral merger approved
27th July 2016
Should the monopoly power of the tech titans be broken up?
10th September 2018
Horizontal and Vertical Collusion
Topic Videos
What is market power?
Topic Videos
Industry Profile: UK Supermarket Industry
Topic Videos
Daily Email Updates
Subscribe to our daily digest and get the day’s content delivered fresh to your inbox every morning at 7am.
Signup for emails